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Abstract 
 
 The opportunistic fungal pathogen Candida albicans causes serious hematogenic hospital 
acquired candidiasis with worldwide impact on public health. Because of its importance as a 
nosocomial etiologic agent, C. albicans genome has been largely studied to identify intraspecific 
variation and several typing methods have been developed to distinguish closely related strains. 
Mitochondrial DNA can be useful for this purpose because, as compared to nuclear DNA, its 
higher mutational load and evolutionary rate readily reveals microvariants. Accordingly, we 
sequenced and assembled, with 8 fold coverage, the mitochondrial genomes of two C. albicans 
clinical isolates (L296 and L757) and compared these sequences with the genome sequence of 
reference strain SC5314. The genome alignment of 33,928 positions revealed 372 polymorphic 
sites being 230 in coding and 142 in non-coding regions. Three intergenic regions located 
between genes tRNAGly/COX1, NAD3/COB and ssurRNA/NAD4L, named IG1, IG2 and IG3 
respectively, which showed high number of neutral substitutions, were amplified and sequenced 
from 18 clinical isolates from different locations in Latin America and 2 ATCC standard C. 
albicans strains. High variability of sequence and size were observed, ranging up to 56bp size 
difference and phylogenies based on IG1, IG2 and IG3 revealed three groups. Insertions of up 
to 49bp were observed exclusively in Argentinean strains relative to the other sequences which 
could suggest clustering by geographical polymorphism. Because of neutral evolution, high 
variability, easy isolation by PCR and full length sequencing these mitochondrial intergenic 
regions can contribute with a novel perspective in molecular studies of C. albicans isolates, 
complementing well established multilocus sequence typing methods. 
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1. Introduction 
 
 Candida spp. are important opportunistic fungal pathogens and one of the major leading 
causes of superficial and life-threatening bloodstream infections, especially in hospitalized 
immunocompromised hosts (Koh et al. 2008; Lim et al. 2012; Pfaller,1996). In Brazil, the overall 
incidence reported in a surveillance study showed 2.49 cases per 1,000 hospital admissions 
which is 2 to 15 times greater than in countries in the Northern Hemisphere, such as the United 
States (Colombo et al. 2006). The primary source of most of these infections is endogenous, 
though there is severe risk of acquisition of Candida spp. from the hospital environment by 
contaminated plastic devices and staff skin (Dorko et al. 1999; Fanello et al. 2001; Pfaller, 
1996).  
 The genome of C. albicans has been extensively studied to identify intraspecific 
variability and several typing methods were developed to effectively elucidate the epidemiology 
of C. albicans and to discriminate clinical isolates to help identify the source of contamination 
(Cliff et al. 2008; Fanello et al. 2001). DNA fingerprinting methods such as restriction fragment 
length polymorphism (RFLP), randomly amplified polymorphic DNA (RAPD) and pulsed field gel 
electrophoresis (PFGE), have been widely used for C. albicans typing (Fanello et al. 2001; Heo 
et al. 2011; Noumi et al. 2009; Ruiz-Diez et al. 1997). However, these techniques are prone to 
ambiguity and subjective interpretations because of variations in electrophoretic patterns such 
as band size and intensity. Moreover, these techniques are not indicated for estimating genetic 
distances and phylogenetic inference, because they underestimate the real number of 
evolutionary events, are subject to systematic errors and cannot be readily assessed in terms of 
probability models (Mello et al. 1998; Soll, 2000). More reliable molecular studying methods 
based on sequencing, such as the gold standard multilocus sequence typing (MLST), relies on 
the analysis of at least six nuclear housekeeping genes (Robles et al. 2004) and though several 
authors have used C. albicans mtDNA in molecular analysis (Anderson et al. 2001; Aranishi, 
2006; Jacobsen et al. 2008; Sanson and Briones, 2000; Watanabe et al. 2005), more studies 
are needed to investigate fully its intraspecific nucleotide diversity in C. albicans.  
 Mitochondrial DNA (mtDNA) is more susceptible to damage and mutations than nuclear 
DNA, mainly because of the presence of reactive oxygen species generated during ATP 
synthesis and less efficient repair system of gamma DNA polymerase (Kang and Hamasaki, 
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2002; Kaguni, 2004). The high mutation number and the faster evolutionary rate, from 5 to 10 
times higher than nuclear DNA (Brown et al. 1979), makes mtDNA suitable for discrimination of 
closely related organisms and recent evolutionary events. Furthermore, because it is haploid 
and present in multiple copies in cells, greater efforts and high technology are not usually 
required for the amplification and sequencing of specific PCR products. Despite the high 
variability of mitochondrial genes, their use can be limited in genetic analysis of closely related 
populations because of low intraspecific variability, probably constrained by negative selection 
on functional domains (Aranishi, 2006; Sanson and Briones, 2000; Watanabe et al. 2005). Non-
coding regions (e.g. introns, pseudogenes, intergenic) evolve neutrally or are at least 
significantly less susceptible to natural selection and fitness interference than coding regions. 
Therefore, these genomic segments are expected to have a higher number of polymorphic sites 
and to evolve faster, making them interesting sequences to explore intraspecific mitochondrial 
nucleotide variability (Aranishi, 2006; Watanabe et al. 2005).  
 In this study, we have sequenced the complete mitochondrial genomes of two C. 
albicans clinical isolates and compared them with the genome sequence of the reference strain 
SC5314, to identify intraspecific hypervariable sites. We demonstrated that intergenic regions 
evolves under neutrality and are the most variable segments in the mtDNA, interesting features 
that could bring light into the usefulness of these sequences in molecular studies of C. albicans 
microvariability.  
 
 
2. Materials and methods 
 
2.1. Strains and mtDNA isolation.  
C. albicans clinical isolates were obtained from the collection of the “Laboratório Especial 
de Micologia (LEMI), Disciplina de Doenças Infecciosas e Parasitárias (DIPA), Departamento de 
Medicina, Universidade Federal de São Paulo”. 18 isolates were collected from patients with 
hematogenic infection by C. albicans from 1997 to 2010 in different locations in Latin America. 
Two standard C. albicans ATCC (American Type Culture Collection) strains were also used in 
the analysis (Table 1). Cultures were grown in YPD medium (1% yeast extract, 2% peptone, 2% 
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dextrose) at 30ºC before experiments. Mitochondrial DNA for whole genome sequencing or PCR 
amplifications was isolated by the method described previously (Defontaine et al. 1990). 
 
Table 1. C. albicans clinical isolates and accession number of nucleotide sequences used in this study. IG1=tRNA-
Gly/COX1, IG2=NAD3/COB and IG3=ssurRNA/NAD4L.  Brazilian states RJ (Rio de Janeiro); SP (São Paulo); PR 
(Paraná); BA (Bahia). Strains in bold indicate that the complete mitochondrial genome sequence was used as source 
for nucleotide sequence. COB=Cytochrome b, ITS1 and ITS2=rDNA ITS excluding 5.8S rDNA. 
 
 Source  GenBank accession no.  
Strain Clinical Geographic Year  IG1 IG2  IG3 COB ITS1 ITS2 
           
SC5314 Blood USA   NC002653 NC002653 NC002653 NC002653 NC002653 NC002653 
ATCC 
24433 Nail USA   JQ814087 JQ814119 JQ814140 - JX494812 JX494813 
ATCC 
90029 Blood USA   JQ814086 JQ814120 JQ814141 - JX494814 JX494815 
34 ptc Catheter ? ?  JQ814102 JQ814105 JQ814125 - JX494790 JX494791 
L296 Blood Brazil / RJ 1997  JQ864234 JQ864234 JQ864234 JQ864234 JQ814076 JQ814082 
L757 Blood  Brazil / SP 2001  JQ864233 JQ864233 JQ864233 JQ864233 JQ814077 JQ814083 
6965 Blood Brazil / SP 2010  JQ814098 JQ814109 JQ814129 - JX494798 JX494799 
6944A Blood Brazil / SP 2010  JQ814100 JQ814106 JQ814127 - JX494794 JX494795 
7060A Blood Brazil / SP 2010  JQ814097 JQ814123 JQ814130 - JX494800 JX494800 
6945 Blood Brazil / SP 2010  JQ814099 JQ814108 JQ814128 - JX494796 JX494797 
6921 Blood Brazil / PR 2010  JQ814101 JQ814107 JQ814126 - JX494792 JX494792 
7252A Blood Brazil / PR 2010  JQ814094 JQ814112 JQ814133 - JX494804 JX494805 
7251 Blood Brazil / PR 2010  JQ814095 JQ814111 JQ814132 JQ814068 JQ814072 JQ814078 
7082 Blood Brazil / PR 2010  JQ814096 JQ814110 JQ814131 - JX494802 JX494803 
6924 Blood Brazil / BA 2010  JQ814103 JQ814104 JQ814124 - JX494788 JX494789 
5147 Blood Ecuador 2009  JQ814089 JQ814117 JQ814138 - JQ814074 JQ814080 
6592 Blood Ecuador 2009  JQ814091 JQ814115 JQ814136 - JX494808 JX494809 
5982 Blood Argentina 2009  JQ814088 JQ814118 JQ814139 JQ814067 JQ814075 JQ814081 
6779 Blood Argentina 2009  JQ814090 JQ814116 JQ814137 JQ814069 JX494810 JX494811 
6185 Blood Venezuela 2009  JQ814093 JQ814113 JQ814134 - JX494806 JX494807 
6461 Blood Colombia 2009  JQ814092 JQ814114 JQ814135 - JQ814073 JQ814079 
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2.2. Yeast nuclei purification and DNA extraction.  
Yeast nuclei purification was performed according to the method described previously 
(Hahn, 2006). Nuclear DNA was extracted by adding 200 µl of Solution B (100 mM NaCl, 10 mM 
EDTA, 1% Sarkosyl, 50 mM Tris-HCl pH 7.8) and incubated for 30 min at room temperature, 
followed by purification with phenol-chloroform, washed in 70% Ethanol, Ethanol precipitated 
and ressuspended in TE buffer.  
 
2.3. Whole mitochondrial genome sequencing and assembly.  
The complete mitochondrial genome sequences of two C. albicans clinical isolates (L296 
and L757) were obtained using the whole genome shotgun method (Fleischmann et al. 1995). 
For mitochondrial genomic library construction, mtDNA was randomly sheared by sonication 
(Sambrook and Russel, 2001) and fragments of size from 1 to 2kb were blunt cloned into 
pBluescript IISK (Stratagene) prior to sequencing. mtDNA sequences were determined by 
dideoxynucleotide chain termination method of Sanger et al. (1977) using fluorescent BigDye 
terminator cycle sequencing kit (version 3.1; Applied Biosystems) in an ABI Prism 3100 
automated sequencer (Applied Biosystems) according to the manufacturer’s instructions.  
Assembly of finished sequences from chromatograms was generated using Phred (Ewing and 
Green, 1998; Ewing et al. 1998a), Phrap and Consed (Gordon et al. 1998). Sequences were 
considered finished when Phred scores were above 40, which corresponds to less than one 
estimated error per 10 kb assembled.  
 
2.4. Amplification of mitochondrial intergenic regions.  
PCR primers were designed for complete amplification of nucleotide sequences of three 
C. albicans mitochondrial intergenic regions according to the available sequence of the 
reference strain SC5314 (GenBank ID: NC002653.1) (Table 2). Amplification reactions (50 µl) 
consisted of 10 mM dNTP, 10 pmol of each primer (forward and reverse), 10 µl Buffer B (2 mM 
MgCl2), 40 ng mtDNA and 1µl Elongase Enzyme Mix (Invitrogen). For the mitochondrial 
intergenic region located between the genes tRNA-Gly/COX1 (IG1) cycling conditions were 94ºC 
for 5 min, followed by 35 cycles of 94ºC for 40 s, 48ºC for 40 s, 68 ºC for 1 min and a final 
extension step of 68ºC for 7 min; for NAD3/COB  (IG2) conditions were 94ºC for 5 min, 35 
7 
cycles of 94ºC for 45 s, 50ºC for 45 s, 68ºC for 1 min and extension of 68ºC for 7 min while PCR 
cycling conditions for the sequence flanked by ssurRNA/NAD4L (IG3) were 94ºC for 5 min, 
followed by 35 cycles of 94ºC  for 45 s, 48ºC for 45s, 68ºC for 2 min and extension of 68ºC for 7 
min. Amplicons were blunt cloned into pBluescript II SK (Stratagene) before sequencing. 
Sequencing reactions were performed as described previously in the section 2.3. PCR products 
were also sequenced on both strands by using the same primers employed in the amplification. 
 
2.5. Cytochrome b gene (COB) and rDNA ITS (internal transcribed spacer) amplification.  
PCR primers (A and L) were used for complete amplification of COB gene (Table 2). 
Amplification reactions (50 µl) consisted of 10 mM dNTP, 10 pmol of each primer, 10 µl Buffer B 
(2 mM MgCl2), 40 ng mtDNA and 1µl Elongase Enzyme Mix (Invitrogen). Cycling conditions 
were 94ºC for 5 min, followed by 35 cycles of 94º for 40 s, 50ºC for 40 s, 68ºC for 4 min and final 
extension of 68ºC for 7 min. Total genomic DNA was extracted as described previously (Wach et 
al. 1994) and ITS amplification was performed using universal primers ITS1 and ITS4 (Table 2) 
(White et al. 1990). Amplification reactions (25 µl) consisted of 12.5 µl of 2X Master Mix 
(Fermentas), 10 pmol of each specific primer (forward and reverse) and 40 ng of DNA with the 
following cycling conditions: 94ºC for 5 min, 35 cycles of 94ºC for 30 s, 58ºC for 30 s, 72ºC for 
50 min and final extension of 72ºC for 7 min.  COB and ITS PCR products were sequenced on 
both strands as described in section 2.3 using the same corresponding primers. For the 
complete sequencing of COB (2,811 bp), specific internal primers (Primers COB B to COB K - 
Table 2) were also used.  
 
2.6. Comparative sequence analysis.   
Alignment of the whole mitochondrial genomes was made using Geneious 4.8 
(Drummond et al. 2012) by the progressive Mauve algorithm (Darling et al. 2004). Nucleotide 
sequences of mitochondrial intergenic regions, COB and ITS, were aligned using Clustal W 
(Thompson et al. 1994). The overall pairwise mean distances (p-value) of the intergenic regions, 
COB and ITS were estimated using the program MEGA 5 (Tamura et al. 2011) with pairwise 
deletion treatment of gaps.  
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Table 2. Primers used for C. albicans DNA amplification and sequencing. 
Primer Gene or region 
amplified 
Sequence                                                   
5' > 3'   
Amplicon size
(bp) 
RIG 1 forward  tRNA-Gly/COX1 GCCAGGGTCTACCATTA 635 
RIG 1 reverse (IG1) CATAGCACTAACCATACC  
    
RIG 2 forward  NAD3/COB GCGTAGTTATGATAAGGATA 836 
RIG 2 reverse (IG2) GTATTAGATTTACGTGTTGGC  
    
RIG 3 forward  ssurRNA/NAD4L GCTATAAGTTGAAATACAGT 1188 
RIG 3 reverse (IG3) AGTAATGTAGTAATAACAGC  
    
COB A COB GTAGTGGAGGTGCTTATATAC 3109 
COB L  GAGCTATAGTTCACTTACC  
COB B  CTATTGTAAGAAGTGTTACC   
COB C  CATGCTAATGGTGCCTCA  
COB D  CTTTAGGACTATCCGCTTG  
COB E  GAGGTAGTAAACCATTAAAG  
COB F  CCGGTCAATCTTTATTTCC  
COB G  CGTAGTATAGAGAAAGGTT  
COB H  CCACGGTCTTGATTTAGTC  
COB I  GGCAAATGAGTCATTGAGG  
COB J  CAATTGAAGGAGGTGTTAC  
COB K  GCCAATGCATCCTTACTTC  
    
ITS 1 rDNA ITS TCCGTAGGTGAACCTGCGG 536 
ITS 4  TCCTCCGCTTATTGATATGC  
    
ACT 1 forward ACT1 GAAGCTCCAATGAATCCAAAATC 355 
ACT 1 reverse  GTTCGAAATCCAAAGCAACGTAAC  
    
COX 2 forward COX2 ATGCGAGGTATATCGGTTC 947 
COX 2 reverse   GCGATTCCACTAATTAAGG  
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2.7. Phylogenetic inference and testing for neutral evolution.  
Phylogenetic trees were generated by the Bayesian method using the program MrBayes 
(Huelsenbeck and Ronquist, 2001). Trees were inferred from 106 generations sampling a tree in 
every 100 generations until the standard deviation from split frequencies were under 0.01. The 
parameters and the trees were summarized by wasting 25% of the samples obtained (burnin). 
The consensus trees (50%) were then used to determine the posterior probabilities values. 
Substitution models were optimized by ModelTest 3.7 (Posada and Crandall, 1998). All 
phylogenetic trees were then formatted with the FigTree v1.3.1 program 
(http://tree.bio.ed.ac.uk/software/figtree/). Statistical tests of Tajima’s D (Tajima, 1989) and Fu 
and Li’s (Fu and Li, 1993) D* and F* for detection of deviation from the neutral model of 
evolution were performed using DnaSP 5 (Librado and Rozas, 2009).  
 
2.8. Actin and COX2 amplification reactions.  
After nuclei isolation and DNA extraction, a fragment of approximately 350 bp from the 
nuclear gene ACT1 (positions 274 to 628) and the complete sequence of the mitochondrial gene 
COX2 (Table 2), employed as a positive and negative control respectively, were amplified by 
PCR. For ACT1, amplification reaction (25 µl) consisted of 12.5 µl of 2X Master Mix 
(Fermentas), 10 pmol of each specific primer (forward and reverse) and 40 ng of DNA. Cycling 
conditions were 94ºC for 5 min, 35 cycles of 94ºC for 40 s, 54ºC for 40 s, 72ºC for 1 min and 
final extension of 72ºC for 10 min. For COX2, reaction and cycling were the same as described 
for ACT1, except that the primer annealing temperature used was 50ºC. Amplification of 
mitochondrial intergenic regions with the purified nuclei DNA sample was performed according 
to the protocol described elsewhere in section 2.4. 
 
2.9. Nucleotide sequences accession number.  
C. albicans sequences obtained in this study have been deposited in GenBank 
(http://www.ncbi.nlm.nih.gov/nucleotide/) under the accession numbers listed in Table 1.  
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3. Results 
 
3.1. Intraspecific comparative sequence analysis of C. albicans mitochondrial genome.  
 The complete mitochondrial genomes of two C. albicans clinical isolates (L296 and L757) 
were sequenced by the whole genome shotgun approach, with 8-fold coverage. The final 
mtDNA assemblies were 33,928 bp (assembly error: 0.2/10kb) and 33,631 bp (assembly error: 
0.01/10kb) for strains L757 and L296 respectively. Genome annotation was performed using 
program ORF finder as implemented in Geneious 4.8 (Drummond et al. 2012) and was 
consistent with  the annotation of reference strain SC5314 mitochondrial genome (assembly 19, 
available online in the Candida genome database - candidagenome.org), as confirmed by 
BLAST (Basic Local Alignment Search Tool). To avoid redundancy in alignments the two 
identical repeat regions of 6,842 bp present in the C. albicans SC5314 (40,420 bp) mtDNA, were 
represented only once in the final assembly of strains L296 and L757. 
 Alignment of mtDNA from strains L296, L757 and SC5314 revealed 372 polymorphic 
sites in the 33,928 nucleotide sites analyzed, corresponding roughly to 1.1% global variation 
(Fig.1), where 230 (0.68 %) of these polymorphisms are in coding regions and 58.70%  are 
transitions (Table 3). Mutations were concentrated in the third codon positions (90.00%) and 
96.66% were synonymous. The only exception was the gene NAD2 where 3 non-synonymous 
substitutions led to amino acid exchange at positions 97, 319 and 434, being one a substitution 
of isoleucine by valine (both nonpolar amino acids) in the functional domain Oxidored g1 
(http://www.uniprot.org/uniprot/Q9B8D2). As revealed by the alignments, COB and Cytochrome 
c oxydase subunit 1 (COX1) are the most variable genes among strains. These genes are the 
only intron containing genes in C. albicans mtDNA (COB has 3 exons and 2 introns while COX1 
has 5 exons and 4 introns) according to th annotation based on the highly similar sequences of 
C. parapsilosis mtDNA (available in the Candida genome database website). The 2,811 bp 
sequence of COB has 73 variable sites (43 transitions, 29 transversions and 1 deletion), located 
mainly in its introns (94.52%), with a frequency of nucleotide change (substitutions plus indels or 
“gaps”) of 2.59%. COX 1, which has 6,155 bp, has 59 variable sites (35 transitions, 20 
transversions and 4 insertions) also concentrated in introns (69.49%), with a frequency of 
nucleotide change of 0.95%. Genes coding for proteins ATP8, ATP9 and all of the 30 genes 
coding for tRNAs did not show any mutation on both strains in comparison to SC5314. 
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Fig.1. Alignment of C. albicans mitochondrial genomes of strains SC5314, L296 and L757 by the progressive mauve 
algorithm. Map positions of the three mitochondrial intergenic regions characterized in this study IG1 (tRNA-
Gly/COX1), IG2  (NAD3/COB) and IG3 (ssurRNA/NAD4L) in white boxes. Grey boxes indicate coding genes and 
rRNA genes. Small bars indicate tRNA genes. Numbered scale bars indicate distance in base pairs and grey vertical 
bars just below the scale bars indicate the sequence similarity. 
 
 
 The remaining 142 polymorphic sites observed (0.42%) were located in intergenic 
regions. The rate of nucleotide substitution ranged between 4.35% for the 23 bp region between 
genes lsurRNA/tRNA-Ala and 0.8% in the 4,405 bp region flanked by NAD1/COX3a (Table 4). 
The nucleotide variation was higher in intergenic spacers than in mitochondrial genes because 
only 26.66% had the frequency of nucleotide substitution above 1%, while 56.25% of intergenic 
regions exhibited frequency of nucleotide substitution above 1%. Among non-coding 
mitochondrial regions analyzed, three intergenic sequences (tRNA-Gly/COX1, NAD3/COB and 
ssurRNA/NAD4L) were further investigated. These regions, named IG1, IG2 and IG3 
respectively, were selected for PCR amplification and sequencing from additional C. albicans 
strains to investigate their potential as a tool for strain differentiation because of appropriate 
sizes for amplification (519, 758 and 1086 bp respectively), straightforward sequencing (not 
located in repeat regions) and high frequency of nucleotide substitution (above 1%).    
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Table 3. Mutations in mitochondrial genes of C. albicans clinical isolates L296 e L757 relative to the strain SC5314. * 
Genes in one of the two repeat regions present in C. albicans mtDNA. Ts=Transitions, Tv=Transversions, 
Del=Deletions, Ins=Insertions, Ns=Non-synonymous substitution and bp=base pairs. 
     Types of mutation (Numbers observed) 
Gene  Size             
(bp) 
Variable 
sites 
Mutation 
Frequency (%)  
Ts Tv Del Ins Ns 
lsurRNA 3130 29 0.93 13 15 1 - - 
COX2 788 10 1.27 7 3 - - - 
NAD6 440 3 0.68 1 2 - - - 
NAD1 953 3 0.31 1 2 - - - 
*COX3a 809 6 0.74 4 2 - - - 
ATP6 740 8 1.08 6 2 - - - 
NAD2 1427 13 0.91 7 6 - - 3 
NAD3 389 3 0.77 2 1 - - - 
ssurRNA 1461 1 0.07 1 - - - - 
NAD4L 254 1 0.39 - 1 - - - 
NAD5 1658 9 0.54 6 3 - - - 
NAD4 1394 6 0.43 5 1 - - - 
*COX3b 809 6 0.74 4 2 - - - 
COB 2811 73 2.59 43 29 1 - - 
COX1 6155 59 0.95 35 20 - 4 - 
Total    135 89 2 4 3 
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Table 4. Mutations in mitochondrial intergenic regions of C. albicans clinical isolates L296 e L757 relative to the strain SC5314. * 
Intergenic regions in one of the two repeat regions present in C. albicans mtDNA. Ts=Transitions, Tv=Transversions, 
Del=Deletions, Ins=Insertions and bp=base pairs. Bold face indicates IG1 (tRNA-Gly/COX1), IG2  (NAD3/COB) and IG3 
(ssurRNA/NAD4L).  
     Types of mutation (Numbers observed) 
Mitochondrial intergenic 
region 
Size             
(bp) 
 Variable 
sites 
Mutation 
Frequency  
(%)  
Ts Tv Del Ins 
lsurRNA/tRNA-Ala 23 1 4.35 - - - 1 
*NAD1/COX3a  4405 13 0.29 5 8 - - 
*COX3a/tRNA-Lys 39 1 2.56 - 1 - - 
*tRNA-Lys/tRNA-Leu 705 8 1.13 2 6 - - 
*tRNA-Glu/ATP9 542 2 0.37 - 2 - - 
ATP6/ATP8 124 1 0.80 1 - - - 
tRNA-Gly/COX1 519 5 0.96 - 4 1 - 
COX1/tRNA-Arg 139 1 0.72 - 1 - - 
NAD3/COB 758 10 1.19 5 5 - - 
COB/tRNA-Met 126 1 0.80 1 - - - 
ssurRNA/NAD4L 1086 13 1.10 3 9 1 - 
tRNA-Ser/tRNA-Ser 195 3 1.54 - 3 - - 
*tRNA-Met/tRNA-Glu 476 3 0.63 - 3 - - 
*tRNA-Leu/tRNA-Lys 675 8 1.18 2 6 - - 
*tRNA-Lys/COX3b 39 1 2.56 - 1 - - 
*COX3b/lsurRNA 4400 71 1.61 37 32 1 1 
Total    56 81 3 2 
 
 
3.2. Variability of mitochondrial intergenic regions between C. albicans strains.  
The three mitochondrial intergenic regions selected IG1, IG2 and IG3 were sequenced in 
other 16 clinical isolates and 2 standard ATCC strains from different locations (Table 1): United 
States (2), Brazil (9 – São Paulo, Paraná and Bahia), Ecuador (2), Argentina (2), Venezuela (1), 
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Colombia (1) and one from an unknown location, from patients with hematogenic infections.  
Amplicons were obtained using the Elongase Enzyme Mix (Invitrogen) because of the 3’-5’ 
exonuclease activity, which provides higher fidelity in polymerization than common Taq 
polymerase. PCR products were cloned prior to sequencing and the polymorphisms were 
confirmed by sequencing of independent PCR products to exclude artifacts of the amplification 
reaction and heteroplasmic effects. Identical results were obtained by direct sequencing of 
amplicons (data not shown).  
Fig. 2. Polymorphic sites in the mitochondrial intergenic regions IG1 (tRNA-Gly/COX1) (A), IG2 (NAD3/COB) (B), and 
(ssurRNA/NAD4L) (C) of 21 C. albicans clinical isolates and reference strains. Haplotypes are specified in parenthesis 
(A to H). Dots indicate nucleotides identical to the first sequence in the alignment and hyphens indicate indels (gaps). 
 
 The sequences obtained were aligned with their corresponding sequences of strains 
SC5314, L296 and L757, revealing a great variability in size and nucleotide sequence. The 
frequency of nucleotide changes (substitutions plus indels) were 19.84%, 1.98% and 8.65% for 
IG1, IG2 and IG3 respectively.  
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 The alignment of IG1 sequences revealed 22 nucleotide substitutions and 81 indels 
(“gaps”) between strains, totaling 103 variable sites (Fig. 2A). These 21 strains were distributed 
in 7 haplotypes (A to G) and their sequences exhibited great variability in size, ranging from 513 
to 575 bp, with up to 56 bp difference relative to strain SC5314. The intergenic regions of the 2 
Argentinean strains (5982 and 6779) and 1 from Brazil (7251) had identical nucleotide 
sequences between each other and were the most variable respective to other strains, 
especially because of two great indel segments of 16 and 48 bp (Fig. 2A positions 283 and 335). 
The IG2 alignment reveals 14 substitutions and 1 indel. These strain sequences were distributed 
in 8 haplotypes (A to H) (Fig. 2B). Alignment of IG3 sequences showed considerable variability 
between clinical isolates. 35 substitutions and 59 indel sites were observed, resulting in 94 
variable sites distributed in 8 haplotypes (A to H) (Fig. 2C). Sequence sizes diverged up to 41 bp 
relative to strain SC5314, ranging from 1,085 to 1,127bp. The Argentinean strains (5982 and 
6779) and strain 7251 from Brazil also have identical nucleotide sequences and two exclusive 
indels of 6bp and 49bp (Fig. 2C positions 154 and 200).  
 Modeltest (Posada and Crandall, 1998) was used to estimate the best fitting substitution 
model for the intergenic regions aligned. The models selected were TIM1+G, TPM3uf+I and F81 
for IG1, IG2 and IG3, respectively. Bayesian trees were inferred for each sequence alignment 
using the corresponding substitution models. Tree topologies indicated that the isolates were 
distributed in three groups with posterior probabilities values above 60% (Fig. 3). Group 1 is 
formed mainly by isolates with the same or very similar haplotype as the reference strain 
SC5314, with 7 isolates from Brazil, 2 from United States, 1 from Venezuela, 1 from Colombia  
 
and 1 from Ecuador. Groups 2 and 3 are formed by strains that present more divergent 
sequences when compared to strain SC5314. Group 2 is formed by 4 samples from Brazil, 1 
from United States and 1 from Ecuador while group 3 is formed mainly by the Argentinean 
strains (5982 and 6779), with the exception of one strain from Brazil (7251). These three strains 
were the most divergent and had exclusive indels segments of up to 49 bp relative to other 
strains. We assume that these indel segments, as well as the other exclusive polymorphisms 
present in these strains, might be geographically related and that migration could explain the 
presence of the Brazilian strain (7251) in this group. We did not detect any obvious clustering of 
strains in clades directly related to their geographic isolation, except for strains 5982 and 6779  
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Fig. 3. Bayesian phylogenetic trees inferred from the nucleotide sequences of the mitochondrial intergenic regions IG1 
(tRNA-Gly/COX1) (A), IG2 (NAD3/COB) (B) and IG3 (ssurRNA/NAD4L) (C) of 21 C. albicans clinical isolates and 
reference strains. The topology of trees revealed the existence of three distinctive groups with posterior probabilities 
(numbers above branches) above 0.6. Scale bars indicate the number of substitutions per sequence position. Trees 
are depicted as midpoint rooted. The geographical origin of isolates is indicated just besides their identification codes: 
USA=United States, ARG=Argentina, COL=Colombia, ECU=Ecuador, VEN=Venezuela and BA, PR, RJ, SP are the 
Brazilian states of Bahia, Paraná, Rio de Janeiro and São Paulo, respectively. 
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from Argentina that grouped together forming group 3 along with the strain 7251 from Paraná, 
Brazil. To confirm the topology, phylogenetic trees were generated by Neighbor-joining and the 
relatedness of these strains was supported (data not shown).   
 To determine whether the most variable segments of the nucleotide sequences from the 
intergenic regions were not under positive selection, as expected for non-coding regions, it was 
performed the Tajima’s D (Tajima, 1989) and Fu and Li’s (Fu and Li, 1993) D* and F* tests of 
neutrality. The values obtained were not significantly different from zero, which indicates no 
deviation from the neutral model of evolution, and that the three intergenic regions are probably 
not under selective pressure (Table 5). These data indicate that the mutations in these 
intergenic regions IG1, IG2 and IG3 are not affected by natural selection and that estimates of 
distances are expected to follow the orthologous steps in the evolutionary pattern of these 
strains and will not underestimate the real number of events, which is a problem in sequences 
subjected to strong negative selection. 
 
Table 5. Values for Tajima’s D and Fu and Li’s D* and F* obtained as an estimation from deviation of neutral evolution 
for the variable sites present at the mitochondrial intergenic regions analyzed in 21 C. albicans strains. (p>0.10 i.e. not 
significant). 
Intergenic region Tajima (D)  Fu & Li (D*) Fu & Li (F*) 
    
(IG1) tRNA-Gly/COX1 - 0.00041 0.85637 0.7002 
(IG2) NAD3/COB 0.65858 - 0.33631 - 0.05135 
(IG3) ssurRNA/NAD4L 0.20895 0.86175 0.77592 
    
    
 
 
 Because of the great DNA exchange between the nucleus and mitochondria, we tested 
whether intergenic regions IG1, IG2 and IG3 could have been recently transferred to the 
nucleus. DNA was purified from isolated nuclei of C. albicans strain 5982 (Argentinean). 
Mitochondrial intergenic regions sequences from this strain have insertions of up to 49 bp that 
could result from unspecific amplification from nuclear DNA. To confirm if the primers designed 
specifically amplified the corresponding intergenic regions and that their localization was 
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exclusively mitochondrial, the nuclear gene ACT1 and the mitochondrial COX2 were used as 
positive and negative controls, respectively. Amplification of ACT1 was positive, confirming the 
presence of nuclear DNA in the sample, and no amplification of COX2 and IG1, IG2 and IG3 
was observed, indicating that the intergenic regions of interest are exclusively amplified from 
mitochondria and are not artifacts produced from nuclear sequence amplification (Fig. S1, 
Supplementary material). Additionally, we performed nucleotide BLAST using these 
mitochondrial intergenic regions as queries and found no matching outside the mitochondrial 
genome (data not shown).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. S1. Amplification reactions of ACT1, COX2 and mitochondrial intergenic regions tRNA-Gly/COX1, NAD3/COB 
and ssurRNA/NAD4L in nuclear DNA. (n) nuclear DNA; (mt) mitochondrial DNA; (-) negative control (without DNA). 
Amplification of ACT1 and COX2 was used as positive and negative control respectively for nuclear DNA. MtDNA was 
used as a positive control for amplification of the mitochondrial gene COX2 and the intergenic regions.  
 
3.3. Intraspecific sequence variability of COB.  
As revealed by the comparative sequence analysis of the whole mitochondrial genome of 
C. albicans strains L296, L757 and SC5314, COB was the gene with the higher number of 
mutations. To compare COB variability with the intergenic regions, we have amplified and 
sequenced this gene in the group 3 strains (the Argentineans 5982 and 6779 and the Brazilian 
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7251). Sequence alignment of COB along with the sequences from strains L296, L757 and 
SC5314 revealed 79 variable sites (78 substitutions, 1 deletion), and 3 haplotypes (Fig. 4). 
93.67% of the mutations were located in introns and those located in exons were in the third 
codon positions producing only synonymous substitutions. Group 3 strains could not be 
differentiated from each other, and although they showed 6 exclusive polymorphisms, great part 
of these mutations were shared by the 5 strains (87.34%) relatively to SC5314. The frequency of 
nucleotide change (substitutions plus indels) was 2.81%, while the observed for intergenic 
regions IG1 and IG3 in these same strains were 18.49% and 8.38%, respectively. Overall 
pairwise mean distance of COB alignment was 1% while IG1, IG3 and IG2 was 2.3%, 1.6%, and 
0.6% respectively.      
 
 
Fig. 4. Polymorphic nucleotide sites in COB sequences between C. albicans group 3 strains (5982, 7251, 6779) and 
L296, L757 and SC5314. Uppercase letters indicate variable sites localized in introns. Haplotypes are specified in 
parenthesis (A to C). Dots indicate nucleotides identical to the first sequence in the alignment and hyphens indicate 
indels (gaps). 
 
3.4. Comparison of the nuclear marker rDNA ITS and mitochondrial intergenic regions.  
 The rDNA ITS is a widely non-coding nuclear marker used in Candida species 
discrimination. We have sequenced and compared the mitochondrial IG1, IG2 and IG3 
sequences variability to the ITS sequences obtained for the same 21 C. albicans strains. The 
overall pairwise mean distance observed for ITS1 and ITS2 was 0.2 and 0.5% respectively, 
while the average measured distances for IG1, IG2 and IG3 were 1.2%, 0.6% and 0.9% 
respectively, excluding gaps. These data indicate that the mitochondrial intergenic regions are 
significantly more informative, having at least 6 times the potential for strain discrimination than 
the nuclear non-coding marker ITS1. The divergence within IG1, IG2 and IG3 is in fact even 
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greater if considered gaps (indel information). While these strains differed only in 1 site for ITS1 
and 3 sites for ITS2, the IG1, IG2 and IG3 alignments revealed 103, 15 and 94 variable sites 
respectively, which conclusively show the unparalleled informative potential of these regions for 
strain discrimination. In Fig. 5 the phylogenetic tree inferred from the nuclear sequence rDNA 
ITS showed the same basal dichotomy as compared to mtDNA intergenic regions (Fig. 3) but 
because ITS has a  smaller number of substitutions (smaller evolutionary rate), group 3 readily 
identified with mtDNA-IG sequences, is not observed in ITS trees. In other words the mtDNA IG  
shows an equivalent pattern but the polytomies (under 50% majority rule) indicate that ITS has 
less resolution than mtDNA-IG sequences. Therefore, the concern that nuclear and 
mitochondrial sequences, because of differences in ploidy, cell location and segregation could 
be “telling” different evolutionary “stories” is here not supported. Our data and analysis suggest 
that in the case of sequences here compared, the nuclear and mitochondrial sequences tell the 
same “story” although the mitochondrial “tells it” in more detail. The ITS rDNA Bayesian tree 
(Fig. 5) was inferred using the concatenated alignment of ITS1 and ITS2 sequences of  21 C. 
albicans isolates and the K80 transition matrix (Kimura, 1980) as indicated by model fit analysis 
implemented in program Modeltest (Posada and Crandall, 1998).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Bayesian phylogenetic tree of rDNA ITS of Candida albicans isolates and strains. The Bayesian phylogenetic 
tree was inferred from the concatenated alignment of ITS1 and ITS2  nucleotide sequences of 21 C. albicans strains. 
The phylogeny is depicted as midpoint rooted tree. The scale bar indicate the number of substitutions per sequence 
position. 
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4. Discussion 
 
 Molecular typing methods are essential in epidemiology of C. albicans. These methods 
can also be useful in identifying the contamination source of outbreaks in the hospital 
environment, by differentiating strains according to microvariation in their genomes. MtDNA is 
more prone to revealing microvariability than commonly used nuclear targets, because of its 
higher mutational load and evolutionary rate (Clark-Walker, 1991). In this study, we have 
sequenced and compared two complete mitochondrial genomes of C. albicans strains with the 
reference SC5314, to investigate mtDNA variation in C. albicans and identify intraspecific 
hypervariable sites. We identified three intergenic regions, with great variability suitable for 
amplification and sequencing and further investigated their nucleotide diversity, phylogenetic 
pattern and modes of natural selection of mtDNA in C. albicans clinical isolates.     
 Comparative sequence analysis of the mtDNA of strains L296, L757 relative to SC5314, 
indicated mutation hot spots in the mtDNA, as revealed by analysis of mitochondrial gene 
sequences in phylogenetic related animals, such as humans and primates (Galtier et al. 2006).  
With exception of three non-synonymous changes in NAD2, the majority of mutations in the 
coding regions were synonymous and located in the third codon positions. Because mutations in 
these sites do not change the encoded protein, in theory, there is no effect on fitness (neutral) 
and therefore should reflect the evolutionary history of these strains and not adaptive changes 
(Gerber et al. 2001).  
 Approximately 36% (14,607 bp) of C. albicans mitochondrial genome comprises 
intergenic regions, most of them having few base pairs (up to 200 bp) or being located in one of 
the two repetitive portions of the mitochondrial genome, which makes sequencing very difficult. 
However, three of them, flanked by genes tRNA-Gly/COX1, NAD3/COB and ssurRNA/NAD4L, 
designated IG1, IG2 and IG3 respectively, showed potential for use in populational and 
molecular typing studies of C. albicans. Comparison of these regions in 21 C. albicans isolates 
(clinical and reference) showed a high frequency of nucleotide substitution (19.84%, 1.98% and 
8.65% for IG1, IG2 and IG3 respectively), a value higher than most of the observed in the 
mitochondrial genes evaluated in this study. COB and COX1, were the most variable genes in 
the whole mtDNA sequence analysis, but still showed values lower than intergenic regions IG1 
and IG3.  
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 COB variability had already been used in inter and intraspecific molecular typing studies, 
including yeasts, such as genera Candida and Trichosporon (Biswas et al. 2001; Biswas et al. 
2005; Yokoyama et al. 2000). Sequence comparison of COB between group 3 strains (5982, 
6779 and 7251) with L296, L757 and SC5314, although having a high number of variable sites 
(79), including 6 exclusive for the group 3 strains, were not able to differentiate each sequence 
within group 3 since they shared the same polymorphisms. Intergenic regions IG1 and IG3 
beyond enabling the discrimination of group 3 strains also showed a frequency of nucleotide 
substitution almost 6 and 3 times higher than COB, respectively. Biswas et al. (2001), typing of 
32 C. albicans strains, found only three variable sites in a 396 bp segment, which corresponds 
to a frequency of nucleotide substitution of only 0.76%. Despite the high variation, intergenic 
regions are smaller (519 to 1086bp), easier to amplify and require fewer primers for full length 
sequencing.  
 Mutations in non-coding regions occur more frequently than synonymous changes in 
coding sequences and are among the most common evolutionary changes at the molecular 
level (Kimura, 1983). This higher number of mutations leads to faster evolutionary rates when 
compared to nuclear and mitochondrial genes, which makes them a good tool for studying 
closely related isolates (Watanabe et al. 2005). Ghikas et al. (2010) evaluated the potential of 
variations in the mitochondrial intergenic regions in intraspecific discrimination of the 
entomopathogenic fungus Beauveria bassiana. Analysis of the nucleotide sequences between 
genes NAD3/ATP9 and ATP6/ssurRNA showed that their sizes were extremely variable among 
strains (73 and 200 bp difference respectively) and that, due to the large variability, these 
mitochondrial intergenic sequences allowed a better differentiation of strains than the sequence 
of the widely used nuclear marker rDNA ITS1-5.8S-ITS2. Furthermore, the authors also showed 
that although phylogenetic trees using the two separate data grouped the strains in similar 
clades, trees using concatenated ITS1 and mitochondrial intergenic regions data, resulted in 
subdivision of the major clade into seven distinct subgroups with some geographic association. 
In our analysis, the non-coding nuclear marker rDNA ITS also showed reduced number of 
polymorphisms among C. albicans strains than the mitochondrial non-coding IG1, IG2 and IG3. 
While ITS1 sequences showed only 1 polymorphic site, the mitochondrial intergenic regions 
showed up to 103 variations which indicate a 6 times greater variability among intraspecific 
isolates. In addition, sequences of intergenic regions allowed discrimination of these strains in 
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three groups, including geographic differentiation of the Argentinean strains, while rDNA ITS 
could not (Fig. 5).  
 Although Candida spp. are human opportunistic pathogens with worldwide distribution, 
the existence of certain differences between isolates from different geographical locations is still 
expected and tend to increase with migration. This is possibly due to the action of independent 
evolutionary events in each strain, in separate areas and/or the existence of local reservoirs 
(non migratory) that are able to maintain certain strains associated with specific locations (Odds 
et al. 2007; Wrobel et al. 2008). Sanson and Briones (2000) studied COX2 sequences of C. 
glabrata mtDNA and concluded that two polymorphic positions could be correlated with their 
geographical origin, discriminating strains from Brazil and United States. Nucleotide sequences 
from mitochondrial intergenic regions here analyzed were able to differentiate the Argentinean 
strains from others. The fact that a clinical isolate from the state of Paraná (Brazil) presented the 
same haplotype as these can suggest that the exclusive variations in their sequences are 
geographically related and the presence of such strain in this group is due to a migration event, 
especially because Paraná State borders Argentina. We have no further information about the 
patient’s origin and in which city the isolate was obtained. Commonly the source of the 
individual’s infection is the fungus present in his own microbiota, so the geographic location 
where the sample was isolated may not literally represent their reservoir and place of origin. In 
our analysis, no geographic association could be made with the clades observed in the 
phylogenetic inferences, except for the Argentinean strains. Molecular typing studies using 
MLST in C. albicans isolates tend to cluster them according to their geographical location; 
however, when using larger databases, these geographic data often become diluted and is no 
longer possible to make this distinction, only some suggestions of geographical enrichment of 
related strains (Odds et al. 2007). For this reason, further analysis, with a greater number of 
isolates, are needed to address the use of these intergenic regions for de facto utility as typing 
marker.   
 Some disadvantages may arise from the use of mtDNA as a molecular marker. In yeast, 
mtDNA escapes into the nucleus in a remarkably high frequency, although the opposite is not so 
often (Thorsness and Fox, 1990). Some technical problems arising from its use may be a 
consequence of displacement and insertion of fragments of mtDNA into the nuclear DNA, which 
can still be amplified with conserved primers, complicating and confusing the sequence analysis 
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(Zhang and Hewitt, 1996; Bensasson et al. 2001). In this study, we were not able to amplify the 
selected mitochondrial intergenic regions in nuclear DNA or identify any similarity of these 
sequences with nuclear counterparts, confirming that the intergenic regions amplified actually 
are located in the mitochondria (Fig. S1- Supplementary material).  
 The use of mtDNA in populational studies may also be discouraged by indications that 
mtDNA is not strictly neutral and may be subject to positive selection more often than it is 
believed (Ballard and Kreitman, 1995; Hurst and Jiggins, 2005) because of the constant 
interaction with nuclear proteins, including the formation of four of the five complexes involved in 
electron transport chain and the vital importance of ATP for cell function (Ballard and Rand, 
2005). Accordingly, it is recommended that population studies using mtDNA include statistical 
tests of neutrality (Ballard and Kreitman, 1995). In our study, we tested whether the nucleotide 
sequences of variable intergenic regions were under the effect of selective pressure by the 
methods of Tajima and Fu and Li (Fu and Li, 1993; Tajima, 1989). There were no deviations 
from neutrality, indicating that the variations found in the nucleotide sequences are in 
accordance with the neutral model of evolution, enhancing the potential use of these regions in 
typing studies due to its unconstrained variability.  
 
 
5. Conclusions 
 
 The three mitochondrial intergenic regions analyzed here are easily obtained by PCR, 
sequencing and do not generate data that are dependent on subjective interpretation. Moreover, 
with the primers designed, they are also successfully amplified with total genomic DNA isolation 
(Wach et al. 1994), which is much faster and simpler to perform than mtDNA extraction (data not 
shown). These intergenic regions also showed high variability, even higher than mitochondrial 
genes and the non-coding nuclear marker ITS and showed a few polymorphisms that may be 
geographic related. Further analysis, with a larger and variable number of samples, is required 
to investigate the full potential of these mutations to discriminate geographic variants of C. 
albicans. Nevertheless, our data show, for the first time that mitochondrial intergenic regions 
IG1, IG2 and IG3, which evolves under neutrality and have a high nucleotide variability, can be 
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expected to contribute in molecular studies concerning C. albicans strains along with other well 
established methods, such as MLST.  
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